F

Fennec Pharmaceuticals
D

FENC

6.66500
USD
0.05
(0.68%)
مغلق
حجم التداول
2,148
الربح لكل سهم
-0
العائد الربحي
-
P/E
-167
حجم السوق
182,835,840
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.04000
    (-0.69%)
    5.78000 USD
    A
    ABUS
    -0.01500
    (-0.44%)
    3.42500 USD
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    ACRS
    -0.08000
    (-3.45%)
    2.24000 USD
    A
    ASRT
    -0.00570
    (-0.70%)
    0.80620 USD
    المزيد
الأخبار
المقالات

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.